Currently, RxSight Inc [RXST] is trading at $37.20, down -2.21%. An important factor to consider is whether the stock is rising or falling in short-term value. The RXST shares have lost -1.01% over the last week, with a monthly amount drifted -16.70%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on December 11, 2024, when Wells Fargo downgraded its rating to a Equal Weight and also revised its price target to $42 from $56. Previously, UBS started tracking the stock with Buy rating on December 06, 2024, and set its price target to $52. On October 29, 2024, Jefferies initiated with a Buy rating and assigned a price target of $72 on the stock. Needham reiterated its Buy rating and increased its price target to $66 on August 20, 2024. Needham reiterated its recommendation of a Buy and reduced its price target to $54 on August 06, 2024. BTIG Research reiterated a Buy rating for this stock on May 07, 2024, and upped its price target to $72. In a note dated December 13, 2023, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $31 to $42.
This stock has fluctuated between a low of $34.92 and a high of $66.54 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $70.14 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $37.20 at the most recent close of the market. An investor can expect a potential return of 88.55% based on the average RXST price forecast.
Analyzing the RXST fundamentals
Trailing Twelve Months sales for RxSight Inc [NASDAQ:RXST] were 128.29M which represents 59.08% growth. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.14 and Total Capital is -0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.47 points at the first support level, and at 35.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.17, and for the 2nd resistance point, it is at 39.13.
Ratios To Look Out For
To put it in perspective, the Current Ratio for RxSight Inc [NASDAQ:RXST] is 12.67. On the other hand, the Quick Ratio is 11.71, and the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 11.69, the price to book ratio is 5.40.
Transactions by insiders
Recent insider trading involved Goldshleger Ilya, that happened on Nov 29 ’24 when 3105.0 shares were sold. Officer, ILYA GOLDSHLEGER completed a deal on Nov 29 ’24 to buy 3105.0 shares. Meanwhile, Director Maniar Shweta sold 3782.0 shares on Nov 26 ’24.
